Wiersinga WJ - Search Results

1

Reframing sepsis immunobiology for translation: towards informative subtyping and targeted immunomodulatory therapies.

Shankar-Hari M, Calandra T, Soares MP, Bauer M, Wiersinga WJ, Prescott HC, Knight JC, Baillie KJ, Bos LDJ, Derde LPG, Finfer S, Hotchkiss RS, Marshall J, Openshaw PJM, Seymour CW, Venet F, Vincent JL, Le Tourneau C, Maitland-van der Zee AH, McInnes IB, van der Poll T. Shankar-Hari M, et al. Among authors: wiersinga wj. Lancet Respir Med. 2024 Apr;12(4):323-336. doi: 10.1016/S2213-2600(23)00468-X. Epub 2024 Feb 23. Lancet Respir Med. 2024. PMID: 38408467 Free PMC article. Review.

2

Gene-expression profiles in murine melioidosis.

Wiersinga WJ, Dessing MC, van der Poll T. Wiersinga WJ, et al. Microbes Infect. 2008 Jul;10(8):868-77. doi: 10.1016/j.micinf.2008.04.019. Epub 2008 May 7. Microbes Infect. 2008. PMID: 18653369 Free article.

3

MyD88 dependent signaling contributes to protective host defense against Burkholderia pseudomallei.

Wiersinga WJ, Wieland CW, Roelofs JJ, van der Poll T. Wiersinga WJ, et al. PLoS One. 2008;3(10):e3494. doi: 10.1371/journal.pone.0003494. Epub 2008 Oct 23. PLoS One. 2008. PMID: 18946505 Free PMC article.

4

Immunity to Burkholderia pseudomallei.

Wiersinga WJ, van der Poll T. Wiersinga WJ, et al. Curr Opin Infect Dis. 2009 Apr;22(2):102-8. doi: 10.1097/QCO.0b013e328322e727. Curr Opin Infect Dis. 2009. PMID: 19276877 Review.

5

Burkholderia pseudomallei tropism and the melioidosis road map.

Wiersinga WJ, van der Poll T. Wiersinga WJ, et al. J Infect Dis. 2009 Jun 15;199(12):1720-2. doi: 10.1086/599211. J Infect Dis. 2009. PMID: 19456227 No abstract available.

6

Expression and function of macrophage migration inhibitory factor (MIF) in melioidosis.

Wiersinga WJ, Calandra T, Kager LM, van der Windt GJ, Roger T, le Roy D, Florquin S, Peacock SJ, Sweep FC, van der Poll T. Wiersinga WJ, et al. PLoS Negl Trop Dis. 2010 Feb 16;4(2):e605. doi: 10.1371/journal.pntd.0000605. PLoS Negl Trop Dis. 2010. PMID: 20169062 Free PMC article.

7

[Sepsis: new insights into its pathogenesis and treatment].

Wiersinga WJ, van der Poll T. Wiersinga WJ, et al. Ned Tijdschr Geneeskd. 2010;154:A1130. Ned Tijdschr Geneeskd. 2010. PMID: 20170566 Review. Dutch.

8

Osteopontin impairs host defense during established gram-negative sepsis caused by Burkholderia pseudomallei (melioidosis).

van der Windt GJ, Wiersinga WJ, Wieland CW, Tjia IC, Day NP, Peacock SJ, Florquin S, van der Poll T. van der Windt GJ, et al. Among authors: wiersinga wj. PLoS Negl Trop Dis. 2010 Aug 31;4(8):e806. doi: 10.1371/journal.pntd.0000806. PLoS Negl Trop Dis. 2010. PMID: 20824216 Free PMC article.

9

Diabetes does not influence activation of coagulation, fibrinolysis or anticoagulant pathways in Gram-negative sepsis (melioidosis).

Koh GC, Meijers JC, Maude RR, Limmathurotsakul D, Day NP, Peacock SJ, van der Poll T, Wiersinga WJ. Koh GC, et al. Among authors: wiersinga wj. Thromb Haemost. 2011 Dec;106(6):1139-48. doi: 10.1160/TH11-07-0504. Epub 2011 Oct 6. Thromb Haemost. 2011. PMID: 21979378

10

Endogenous tissue-type plasminogen activator impairs host defense during severe experimental Gram-negative sepsis (melioidosis)*.

Kager LM, Wiersinga WJ, Roelofs JJ, Meijers JC, Levi M, Van't Veer C, van der Poll T. Kager LM, et al. Among authors: wiersinga wj. Crit Care Med. 2012 Jul;40(7):2168-75. doi: 10.1097/CCM.0b013e31824ea05e. Crit Care Med. 2012. PMID: 22564963

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

310 results

Search Page